The Bladder Cancer Advocacy Network (BCAN) is pleased to announce two 2020 Young Investigator Awards (YIA), to support the development of outstanding early-career research scientists and clinical cancer research investigators.
An Extraordinary Healer essay honoring Claudia Davis, RN, OCN, CBCN [Community North, Community Health Network in Indianapolis, Indiana]
Soup, cider and salmon help keep the body full and fueled when it’s frigid outdoors.
Preliminary results of two new targeted therapies, now in late-stage clinical trials, hold much promise for men with hormone-refractory, or castration-resistant, prostate cancer.
An Extraordinary Healer essay honoring KAITLYN WHITEWATER, B.S.N., RN [SAINT FRANCIS HOSPITAL, 7 WEST ONCOLOGY/BONE MARROW TRANSPLANT UNIT, TULSA, OKLAHOMA]
FOR 19 YEARS, Anne Todd served as a secretary in an oncology office where the doctor enjoyed teaching her about the disease.
When Joanne Lam was diagnosed with bladder cancer, her husband showed unwavering devotion in caring for her. Now it's her turn to be his caregiver.
Low-grade gliomas may be classified into three distinct prognostic categories based on genomic data.
Michael F. Press, M.D., Ph.D., shed light on the role of the receptor in breast cancer in a presentation during the 2017 Miami Breast Cancer Conference.
Patients with lung cancer are encouraged to participate in the new modules that will capture data to help gain insights into their treatment path and treatment options.
Practitioners see benefits of tai chi after cancer, while researchers have only begun to look.
This essay was written by Dr. Kevin Yiee, CHI Health St. Elizabeth, nominating registered oncology-certified nurse Robin Devries for CURE®’s 2019 Extraordinary Healer® Award.
I WOULD LIKE TO NOMINATE one of our current nurses, the extraordinary Ann E. Grotz, a registered nurse at Compass Oncology, for this year's award.
When one woman experienced symptoms of chronic lymphocytic leukemia, people blamed her nerves and told her to rest. Instead, she listened to her body.
Mark Heaney, M.D., Ph.D., Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, discusses the pros and cons of patients with myeloproliferative neoplasms (MPNs) researching their diagnosis online.
In this nomination essay for the CURE® Extraordinary Healer® Award, Cora Beth Hartfield honors finalist Angela Hammack, B.S.N., RN, OCN.
Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Sidney Kimmel Cancer Center, discusses plans to maintain momentum on the Cancer Moonshot initiative.
Susan Melvin Hill, patient advocate, tells her MPN story and discusses how she helps patients with myeloproliferative neoplasms (MPNs) in Idaho.
Having been a 12-year cancer survivor, metastatic since 2006, I've gained a lot of experience with what long-term palliative care looks and feels like.
The old and the new in myeloma therapy give patients more options.
Susan Krigel, from the Midwest Cancer Alliance, discusses the effect of fear of recurrence on a cancer survivor's quality of life.
An endometrial cancer survivor runs to raise awareness for a disease many don’t want to talk about.
Before getting genetic testing for hereditary ovarian, breast or other cancers, make sure the company providing it is both reputable and qualified.
A cancer diagnosis can happen so fast, it takes a lot to wrap one’s mind around it; however, Imerman Angels – a Chicago-based, global, peer-to-peer nonprofit support group – is here to help.